W.R. Berkley Corp’s Apexigen, Inc. Common Stock APGN Stock Holding History

W.R. Berkley Corp’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-152,926	Closed	-$1.55M	–	538
2022 Q2	$1.55M	Buy	152,926 +75,360	+97%	+$763K	0.08%	256
2022 Q1	$782K	Hold	77,566	–	–	0.04%	412
2021 Q4	$776K	Buy	77,566 +3,140	+4%	+$31.3K	0.04%	404
2021 Q3	$740K	Buy	74,426 +19,425	+35%	+$192K	0.05%	301
2021 Q2	$546K	Hold	55,001	–	–	0.05%	229
2021 Q1	$541K	Buy	+55,001	New	+$550K	0.06%	190

Other funds holding APGN

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

W.R. Berkley Corp's APGN Position: Q3 2022 in Review

W.R. Berkley Corp sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 152,926 shares — an estimated $1.55M sold.

W.R. Berkley Corp first reported a position in APGN in Q1 2021 and held it in 6 quarters. The position peaked at $1.55M in Q2 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

W.R. Berkley Corp reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
W.R. Berkley Corp sold 152,926 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $1.55M.
W.R. Berkley Corp first reported a position in Apexigen, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
W.R. Berkley Corp's Apexigen, Inc. Common Stock position peaked at $1.55M in Q2 2022.
18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on W.R. Berkley Corp's 13F filing for Q3 2022, filed 14 Nov 2022.